CEACAM5 and gastrointestinal stromal tumor: The sensitivity of the Positive‐Gastric‐GIST‐PG‐CEA was as high as 91% in tumors ≤ 1 cm (10 out of 11 patients) and in patients younger than 50 years (20/22).